National Institutes of Health (NIH) Cancer Moonshot funded research requires all data and publications to be open and freely accessible.
posted by:
Jason E. B. , On: Aug. 18, 2022, 1:46 p.m.
Post update history
Subject: National Institutes of Health (NIH) Cancer Moonshot funded research requires all data and publications to be open and freely accessible. Content: Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.
Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.
National Institutes of Health (NIH) Cancer Moonshot funded research requires all data and publications to be open and freely accessible.
Please provide your inputs before proceeding.
Please provide your details.
Please select valid reason to mark this as an inappropriate.
Post a reply
Re: National Institutes of Health (NIH) Cancer Moonshot funded research requires all data and publications to be open and freely accessible.
posted by:
Jason E. B. , On: Aug. 18, 2022, 1:52 p.m.
Post update history
Subject: Re: National Institutes of Health (NIH) Cancer Moonshot funded research requires all data and publications to be open and freely accessible. Content:
NCI Cancer Moonshot℠ Public Access and Data Sharing Policy
Consistent with the critical goals of NCI's Cancer Moonshot℠ to accelerate cancer research by enhancing data sharing and making evidence-based approaches to cancer therapy more broadly available to patients, NCI recognizes that the full value of NCI-Supported Cancer Moonshot Research Projects can only be realized if Publications and Underlying Primary Data (as defined below) are disseminated as promptly and broadly as possible. Much of the urgency highlighted by the Cancer Moonshot and in the Blue Ribbon Panel’s recommendations to the National Cancer Advisory Board (NCAB) in 2016 emphasizes that the rapid availability of cancer publications and the primary data behind it promotes dissemination of new knowledge, enhances reproducibility, and accelerates the ability of researchers to build upon cancer research to make new discoveries.
Through the Cancer Moonshot Public Access and Data Sharing Policy (the "Policy"), NCI seeks to create an infrastructure that addresses the recommendation of the Blue Ribbon Panel’s Enhanced Data Sharing working group to the NCAB that researchers, clinicians, and patients collaborate in sharing their collective data and knowledge about cancer to accelerate progress towards improving cancer outcomes. The NCAB subsequently accepted this recommendation and recommended it to NCI.
Changed on Aug. 18, 2022, 1:52 p.m.Current
NCI Cancer Moonshot℠ Public Access and Data Sharing Policy
Consistent with the critical goals of NCI's Cancer Moonshot℠ to accelerate cancer research by enhancing data sharing and making evidence-based approaches to cancer therapy more broadly available to patients, NCI recognizes that the full value of NCI-Supported Cancer Moonshot Research Projects can only be realized if Publications and Underlying Primary Data (as defined below) are disseminated as promptly and broadly as possible. Much of the urgency highlighted by the Cancer Moonshot and in the Blue Ribbon Panel’s recommendations to the National Cancer Advisory Board (NCAB) in 2016 emphasizes that the rapid availability of cancer publications and the primary data behind it promotes dissemination of new knowledge, enhances reproducibility, and accelerates the ability of researchers to build upon cancer research to make new discoveries.
Through the Cancer Moonshot Public Access and Data Sharing Policy (the "Policy"), NCI seeks to create an infrastructure that addresses the recommendation of the Blue Ribbon Panel’s Enhanced Data Sharing working group to the NCAB that researchers, clinicians, and patients collaborate in sharing their collective data and knowledge about cancer to accelerate progress towards improving cancer outcomes. The NCAB subsequently accepted this recommendation and recommended it to NCI.
